(5Z)-5-(4-aminobenzylidene)-2-thioxo-1,3-thiazolidin-4-one | 99361-26-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (5Z)-5-(4-aminobenzylidene)-2-thioxo-1,3-thiazolidin-4-one
• 英文别名: (Z)-5-(4-aminobenzylidene)-2-thioxothiazolidin-4-one；(5Z)-5-(4-aminobenzylidene)-2-thioxothiazolidin-4-one；5-(4-amino-benzylidene)-2-thioxo-thiazolidin-4-one；5-(4-Amino-benzyliden)-2-thioxo-thiazolidin-4-on；(5Z)-5-[(4-aminophenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one
• CAS: 99361-26-9
• 化学式: C₁₀H₈N₂OS₂
• 分子量: 236.318
• InChiKey: JZCFZLIAXVFDMF-YVMONPNESA-N

物化性质

• 熔点：
  >290 °C
• 密度：
  1.49±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  113
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (5Z)-5-(4-aminobenzylidene)-2-thioxo-1,3-thiazolidin-4-one 在 溶剂黄146 、 三乙胺 作用下， 以 甲醇 为溶剂， 反应 45.0h， 生成 (R,Z)-dimethyl 2-(3-((3-methoxy-3-oxo-N-(4-((4-oxo-2-thioxothiazolidin-5-ylidene)methyl)phenyl)propanamido)methyl)benzamido)pentanedioate
  参考文献：
  名称：

  Structure-Based Design of a New Series of d-Glutamic Acid Based Inhibitors of Bacterial UDP-N-acetylmuramoyl-l-alanine:d-glutamate Ligase (MurD)

  摘要：

  MurD ligase is one of the key enzymes participating in the intracellular steps of peptidoglycan biosynthesis and constitutes a viable target in the search for novel antibacterial drugs to combat bacterial drug-resistance. We have designed, synthesized, and evaluated a new series of D-glutamic acid-based Escherichia colt MurD inhibitors incorporating the 5-benzylidenethiazolidin-4-one scaffold. The crystal structure of 16 in the MurD active site has provided a good starting point for the design of structurally optimized inhibitors 73-75 endowed with improved MurD inhibitory potency (IC50 between 3 and 7 mu M). Inhibitors 74 and 75 showed weak activity against Gram-positive Staphylococcus aureus and Enterococcus faecalis. Compounds 73-75, with IC50 values in the low micromolar range, represent the most potent D-Glu-based MurD inhibitors reported to date.

  DOI：

  10.1021/jm2002525
• 作为产物：
  描述：

  (5E)-2-疏基-5-(4-硝基亚苄基)-1,3-噻唑-4(5H)-酮 在 tin(II) chloride dihdyrate 作用下， 以 乙醇 为溶剂， 反应 4.0h， 以88%的产率得到(5Z)-5-(4-aminobenzylidene)-2-thioxo-1,3-thiazolidin-4-one
  参考文献：
  名称：

  苯并恶唑基连接的亚苄基罗丹宁及其类似物作为新型抗糖尿病药物：合成、分子对接和体外研究

  摘要：

  合成了具有噻唑烷二酮、罗丹宁、乙内酰脲和硫代乙内酰脲部分的苯并恶唑连接的间位和对位取代的新化学实体 ( 5a – 5h )，并通过1 H NMR、13 C NMR、FT-IR 和 HRMS 光谱研究表征。此外，与用作标准药物的阿卡波糖相比，所有化合物都筛选了 α-葡萄糖苷酶抑制活性，并得到了在 α-葡萄糖苷酶活性位点（PDB 代码：3TOP）的分子对接研究的进一步支持。在八种测试化合物中，发现5d是最有效的 α-葡萄糖苷酶抑制剂 (IC 50 = 9.48 ± 0.36 µM)，在苯环的间位取代了罗丹宁部分。

  DOI：

  10.1007/s00044-021-02781-y

文献信息

• Privileged Scaffolds or Promiscuous Binders: A Comparative Study on Rhodanines and Related Heterocycles in Medicinal Chemistry
  作者：Thomas Mendgen、Christian Steuer、Christian D. Klein

  DOI：10.1021/jm201243p

  日期：2012.1.26

  campaigns, we decided to perform a systematic study on their promiscuity. An amount of 163 rhodanines, hydantoins, thiohydantoins, and thiazolidinediones were synthesized and tested against several targets. The compounds were also characterized with respect to aggregation and electrophilic reactivity, and the binding modes of rhodanines and related compounds in published X-ray cocrystal structures were analyzed

  罗丹宁和具有多个杂原子的相关五元杂环最近因在筛选活动中表现为“频繁的杀手”而成为非选择性化合物，因此在药物发现中几乎没有价值。但是，这种判断似乎主要是基于轶事证据。在筛选活动中鉴定出多种罗丹宁和相关化合物后，我们决定对它们的滥交进行系统的研究。合成了163种罗丹宁，乙内酰脲，硫代乙内酰脲和噻唑烷二酮，并针对几个目标进行了测试。还针对聚集和亲电反应性对化合物进行了表征，并分析了罗丹宁与相关化合物在已发表的X射线共晶结构中的结合模式。结果表明，环外，若丹宁和硫代乙内酰脲中的双键硫原子除具有其他结构特征外，还为极性相互作用和氢键提供了特别高的相互作用位点密度。这会导致“筛选范围”内浓度的混杂行为，但不应视为将此类筛选命中排除在进一步开发之外的一般剔除标准。建议将针对靶标亲和力和选择性的特殊标准应用于这些类型的化合物，并因此以有用的方式利用其特殊和潜在有价值的生物分子结合特性。这会导致“筛选范围”
• Andreasch, Monatshefte fur Chemie, 1918, vol. 39, p. 426
  作者：Andreasch

  DOI：——

  日期：——
• Synthesis and biological evaluation of new glutamic acid-based inhibitors of MurD ligase
  作者：Tihomir Tomašić、Nace Zidar、Veronika Rupnik、Andreja Kovač、Didier Blanot、Stanislav Gobec、Danijel Kikelj、Lucija Peterlin Mašič

  DOI：10.1016/j.bmcl.2008.10.129

  日期：2009.1

  Mur ligases catalyze the biosynthesis of the UDP-MurNAc-pentapeptide precursor of peptidoglycan, an essential polymer of bacterial cell-wall. They constitute attractive targets for the development of novel antibacterial agents. Here we report on the synthesis of a series of 2,4-diaminoquinazolines, quinazoline-2,4(1H,3H)-diones, 5-benzylidenerhodanines and 5-benzylidenethiazolidine-2,4-diones and their inhibitory activities against MurD from Escherichia coli. Compounds (R)-27 and (S)-27 showed inhibitory activity against MurD with IC50 values of 174 and 206 mu M, respectively, which makes them promising starting points for optimization. (C) 2008 Elsevier Ltd. All rights reserved.
• Discovery of Novel 5-Benzylidenerhodanine and 5-Benzylidenethiazolidine-2,4-dione Inhibitors of MurD Ligase
  作者：Nace Zidar、Tihomir Tomašić、Roman Šink、Veronika Rupnik、Andreja Kovač、Samo Turk、Delphine Patin、Didier Blanot、Carlos Contreras Martel、Andréa Dessen、Manica Müller Premru、Anamarija Zega、Stanislav Gobec、Lucija Peterlin Mašič、Danijel Kikelj

  DOI：10.1021/jm100285g

  日期：2010.9.23

  We have designed, synthesized, and evaluated 5-benzylidenerhodanine- and 5-benzylidenethiazolidine-2,4-dione-based compounds as inhibitors of bacterial enzyme MurD with E. coli IC(50) in the range 45-206 μM. The high-resolution crystal structure of MurD in complex with (R,Z)-2-(3-[4-([2,4-dioxothiazolidin-5-ylidene]methyl)phenylamino}methyl)benzamido)pentanedioic acid [(R)-32] revealed details of the binding mode of the inhibitor within the active site and provides a good foundation for structure-based design of a novel generation of MurD inhibitors.
• Structure-Based Design of a New Series of <scp>d</scp>-Glutamic Acid Based Inhibitors of Bacterial UDP-<i>N</i>-acetylmuramoyl-<scp>l</scp>-alanine:<scp>d</scp>-glutamate Ligase (MurD)
  作者：Tihomir Tomašić、Nace Zidar、Roman Šink、Andreja Kovač、Didier Blanot、Carlos Contreras-Martel、Andréa Dessen、Manica Müller-Premru、Anamarija Zega、Stanislav Gobec、Danijel Kikelj、Lucija Peterlin Mašič

  DOI：10.1021/jm2002525

  日期：2011.7.14

  MurD ligase is one of the key enzymes participating in the intracellular steps of peptidoglycan biosynthesis and constitutes a viable target in the search for novel antibacterial drugs to combat bacterial drug-resistance. We have designed, synthesized, and evaluated a new series of D-glutamic acid-based Escherichia colt MurD inhibitors incorporating the 5-benzylidenethiazolidin-4-one scaffold. The crystal structure of 16 in the MurD active site has provided a good starting point for the design of structurally optimized inhibitors 73-75 endowed with improved MurD inhibitory potency (IC50 between 3 and 7 mu M). Inhibitors 74 and 75 showed weak activity against Gram-positive Staphylococcus aureus and Enterococcus faecalis. Compounds 73-75, with IC50 values in the low micromolar range, represent the most potent D-Glu-based MurD inhibitors reported to date.